| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |